Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Azatadine is an H1 receptor antagonist used to treat perennial and allergic rhinitis as well as eustachian tube congestion. Antihistamines such as azatadine appear to compete with histamine for histamine H1- receptor sites on effector cells.
- Mechanism
- Curator reviewed
Antihistamines such as azatadine appear to compete with histamine for histamine H1- receptor sites on effector cells. The antihistamines antagonize those pharmacological effects of histamine which are mediated through activation of H1- receptor sites and thereby reduce the intensity of allergic reactions and tissue injury response involving histamine release.
- Primary indication
- For the relief of the symptoms of upper respiratory mucosal congestion in perennial and allergic rhinitis, and for the relief of nasal congestion and eustachian t.b. congestion.Curator reviewed
- Formula / weight
- C20H22N2 · 290.4021 g/mol (avg)
- First approval
- Canada, 1976
- Code names
- Sch 10649
Resolves to
SEBMTIQKRHYNIT-UHFFFAOYSA-NSMILESCN1CCC(CC1)=C1C2=CC=CC=C2CCC2=C1N=CC=C2What you can answer from here — as of September 23, 2026
Which drugs share a target with Azatadine, and which of those have an active Phase 3 trial?